BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 31637481)

  • 1. [
    Carotenuto A; Giordano B; Dervenoulas G; Wilson H; Veronese M; Chappell Z; Polychronis S; Pagano G; Mackewn J; Turkheimer FE; Williams SCR; Hammers A; Silber E; Brex P; Politis M
    Eur J Nucl Med Mol Imaging; 2020 Feb; 47(2):366-378. PubMed ID: 31637481
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Zhang M; Ni Y; Zhou Q; He L; Meng H; Gao Y; Huang X; Meng H; Li P; Chen M; Wang D; Hu J; Huang Q; Li Y; Chauveau F; Li B; Chen S
    EClinicalMedicine; 2021 Jul; 37():100982. PubMed ID: 34195586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. White Matter Abnormalities in Multiple Sclerosis Evaluated by Quantitative Synthetic MRI, Diffusion Tensor Imaging, and Neurite Orientation Dispersion and Density Imaging.
    Hagiwara A; Kamagata K; Shimoji K; Yokoyama K; Andica C; Hori M; Fujita S; Maekawa T; Irie R; Akashi T; Wada A; Suzuki M; Abe O; Hattori N; Aoki S
    AJNR Am J Neuroradiol; 2019 Oct; 40(10):1642-1648. PubMed ID: 31515218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repurposing radiotracers for myelin imaging: a study comparing 18F-florbetaben, 18F-florbetapir, 18F-flutemetamol,11C-MeDAS, and 11C-PiB.
    Auvity S; Tonietto M; Caillé F; Bodini B; Bottlaender M; Tournier N; Kuhnast B; Stankoff B
    Eur J Nucl Med Mol Imaging; 2020 Feb; 47(2):490-501. PubMed ID: 31686177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo characterization of cortical and white matter neuroaxonal pathology in early multiple sclerosis.
    Granberg T; Fan Q; Treaba CA; Ouellette R; Herranz E; Mangeat G; Louapre C; Cohen-Adad J; Klawiter EC; Sloane JA; Mainero C
    Brain; 2017 Nov; 140(11):2912-2926. PubMed ID: 29053798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-invasive quantification of inflammation, axonal and myelin injury in multiple sclerosis.
    Schiavi S; Petracca M; Sun P; Fleysher L; Cocozza S; El Mendili MM; Signori A; Babb JS; Podranski K; Song SK; Inglese M
    Brain; 2021 Feb; 144(1):213-223. PubMed ID: 33253366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid PET as a marker of normal-appearing white matter early damage in multiple sclerosis: correlation with CSF β-amyloid levels and brain volumes.
    Pietroboni AM; Carandini T; Colombi A; Mercurio M; Ghezzi L; Giulietti G; Scarioni M; Arighi A; Fenoglio C; De Riz MA; Fumagalli GG; Basilico P; Serpente M; Bozzali M; Scarpini E; Galimberti D; Marotta G
    Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):280-287. PubMed ID: 30343433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyloid PET in pseudotumoral multiple sclerosis.
    Matías-Guiu JA; Cabrera-Martín MN; Cortés-Martínez A; Pytel V; Moreno-Ramos T; Oreja-Guevara C; Carreras JL; Matías-Guiu J
    Mult Scler Relat Disord; 2017 Jul; 15():15-17. PubMed ID: 28641766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroinflammation and its relationship to changes in brain volume and white matter lesions in multiple sclerosis.
    Datta G; Colasanti A; Rabiner EA; Gunn RN; Malik O; Ciccarelli O; Nicholas R; Van Vlierberghe E; Van Hecke W; Searle G; Santos-Ribeiro A; Matthews PM
    Brain; 2017 Nov; 140(11):2927-2938. PubMed ID: 29053775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of dimethyl fumarate on gray and white matter pathology in subjects with relapsing multiple sclerosis: a longitudinal study.
    Zivadinov R; Hagemeier J; Bergsland N; Tavazzi E; Weinstock-Guttman B
    Eur J Neurol; 2018 Mar; 25(3):584-e36. PubMed ID: 29316038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hybrid
    Meng H; Zheng S; Yuan S; Zhou Q; Gao Y; Ni Y; He L; Yin D; Zhang M; Chen S
    Transl Neurosci; 2022 Jan; 13(1):120-124. PubMed ID: 35795195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantification of normal-appearing white matter tract integrity in multiple sclerosis: a diffusion kurtosis imaging study.
    de Kouchkovsky I; Fieremans E; Fleysher L; Herbert J; Grossman RI; Inglese M
    J Neurol; 2016 Jun; 263(6):1146-55. PubMed ID: 27094571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Semiautomated Method for Quantification of F 18 Florbetapir PET Images.
    Joshi AD; Pontecorvo MJ; Lu M; Skovronsky DM; Mintun MA; Devous MD
    J Nucl Med; 2015 Nov; 56(11):1736-41. PubMed ID: 26338898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myelin content changes in Clinically Isolated Syndrome and Relapsing- Remitting Multiple Sclerosis: Associations with lesion type and severity of visuomotor impairment.
    Panou Τ; Kavroulakis E; Mastorodemos V; Pouli S; Kalaitzakis G; Spyridaki E; Maris TG; Simos P; Papadaki E
    Mult Scler Relat Disord; 2021 Sep; 54():103108. PubMed ID: 34198031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterning Chronic Active Demyelination in Slowly Expanding/Evolving White Matter MS Lesions.
    Elliott C; Arnold DL; Chen H; Ke C; Zhu L; Chang I; Cahir-McFarland E; Fisher E; Zhu B; Gheuens S; Scaramozza M; Beynon V; Franchimont N; Bradley DP; Belachew S
    AJNR Am J Neuroradiol; 2020 Sep; 41(9):1584-1591. PubMed ID: 32819894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multimodal partial volume correction: Application to [
    Grecchi E; Veronese M; Bodini B; García-Lorenzo D; Battaglini M; Stankoff B; Turkheimer FE
    J Cereb Blood Flow Metab; 2017 Dec; 37(12):3803-3817. PubMed ID: 28569617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Vivo Assessment of Brain White Matter Inflammation in Multiple Sclerosis with (18)F-PBR111 PET.
    Colasanti A; Guo Q; Muhlert N; Giannetti P; Onega M; Newbould RD; Ciccarelli O; Rison S; Thomas C; Nicholas R; Muraro PA; Malik O; Owen DR; Piccini P; Gunn RN; Rabiner EA; Matthews PM
    J Nucl Med; 2014 Jul; 55(7):1112-8. PubMed ID: 24904112
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Datta G; Colasanti A; Kalk N; Owen D; Scott G; Rabiner EA; Gunn RN; Lingford-Hughes A; Malik O; Ciccarelli O; Nicholas R; Nei L; Battaglini M; De Stefano N; Matthews PM
    J Nucl Med; 2017 Sep; 58(9):1477-1482. PubMed ID: 28302760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 18F-florbetapir PET in patients with frontotemporal dementia and Alzheimer disease.
    Kobylecki C; Langheinrich T; Hinz R; Vardy ER; Brown G; Martino ME; Haense C; Richardson AM; Gerhard A; Anton-Rodriguez JM; Snowden JS; Neary D; Pontecorvo MJ; Herholz K
    J Nucl Med; 2015 Mar; 56(3):386-91. PubMed ID: 25655625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Texture analysis in brain T2 and diffusion MRI differentiates histology-verified grey and white matter pathology types in multiple sclerosis.
    Hosseinpour Z; Jonkman L; Oladosu O; Pridham G; Pike GB; Inglese M; Geurts JJ; Zhang Y
    J Neurosci Methods; 2022 Sep; 379():109671. PubMed ID: 35820450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.